Zobrazeno 1 - 10
of 246
pro vyhledávání: '"C. Altisent"'
Autor:
AB Moreno-Castaño, A Ramos, M Pino, R Parra, C Altisent, F Vidal, I Corrales, N Borràs, S Torramadé-Moix, M Palomo, G Escolar, M Diaz-Ricart
Publikováno v:
Platelets, Vol 32, Iss 5, Pp 697-700 (2021)
Identification of qualitative variants of von Willebrand disease (VWD) can be a diagnostic challenge because of discrepant results obtained in the multiple laboratory tests available for its appropriate classification. We report two cases of infreque
Externí odkaz:
https://doaj.org/article/291079f0e4de447cab305789643ecaa6
Autor:
R J, Liesner, M, Abashidze, O, Aleinikova, C, Altisent, M J, Belletrutti, A, Borel-Derlon, M, Carcao, H, Chambost, A K C, Chan, L, Dubey, J, Ducore, N A, Fouzia, M, Gattens, Y, Gruel, B, Guillet, N, Kavardakova, M, El Khorassani, A, Klukowska, T, Lambert, S, Lohade, M, Sigaud, V, Turea, J K M, Wu, V, Vdovin, A, Pavlova, M, Jansen, L, Belyanskaya, O, Walter, S, Knaub, E J, Neufeld
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 24(2)
NuwiqThe study, conducted across 38 centres worldwide, is evaluating 110 true PUPs of all ages and ethnicities enrolled for study up to 100 exposure days (EDs) or 5 years maximum. The primary objective is to assess the immunogenicity of NuwiqData for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8ad964f2c969ee85eeca52a227f040b0
https://pubmed.ncbi.nlm.nih.gov/28815880
https://pubmed.ncbi.nlm.nih.gov/28815880
Publikováno v:
Annals of Physical and Rehabilitation Medicine. 61:e389-e390
Introduction/Background Symptomatic joint hypermobiliy has been associated with bleeding tendency, suggesting that collagen disorders could be the cause in some cases of bleeding. The aim of this study was to examine the clinical characteristics of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87b3e1fec60d02f8f4de808c01903fdc
https://doi.org/10.1016/j.rehab.2018.05.907
https://doi.org/10.1016/j.rehab.2018.05.907
Publikováno v:
Haemophilia. 22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43b3182a75170844c906974450284cd4
https://doi.org/10.1111/hae.12948
https://doi.org/10.1111/hae.12948
Publikováno v:
Haemophilia. 18:789-793
Acquired haemophilia A (AH) is defined as the presence of autoantibodies or inhibitors against factor VIII (FVIII) with a clinical bleeding onset that can be life-threatening. Immunosuppressant therapy must be initiated rapidly to eradicate the inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15c0cf7f5c7d3eb54fd1e6e28bd45bbb
https://doi.org/10.1111/j.1365-2516.2012.02772.x
https://doi.org/10.1111/j.1365-2516.2012.02772.x
Autor:
C, Hermans, C, Altisent, A, Batorova, H, Chambost, P, De Moerloose, A, Karafoulidou, R, Klamroth, M, Richards, B, White, G, Dolan, Thierry, Lambert
Publikováno v:
Haemophilia. 15:639-658
Although most surgical and invasive procedures can be performed safely in patients with haemophilia, the optimal level and duration of replacement therapy required to prevent bleeding complications have not been established conclusively. For providin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e63b924ed32a028f1db85f94669b6a1f
https://doi.org/10.1111/j.1365-2516.2008.01950.x
https://doi.org/10.1111/j.1365-2516.2008.01950.x
Autor:
J, Windyga, G, Dolan, C, Altisent, O, Katsarou, M-F, López Fernández, B, Zülfikar, B, Zulfikar
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 22(1)
Introduction Desamino D-arginine vasopressin (DDAVP or desmopressin) is a useful and effective haemostatic treatment for patients with von Willebrand Disease (VWD). However, there are still issues regarding in which subtypes of VWD DDAVP is appropria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b55fc905309c24f3bd038679dc931e4a
https://pubmed.ncbi.nlm.nih.gov/26207933
https://pubmed.ncbi.nlm.nih.gov/26207933
Autor:
D Tobin, J M Tusell, C Marimoutou, Matthias Egger, Sheila M. Gore, S Darby, R Spooner, Robert J. Biggar, E Schoenbaum, J Learmont, J Rusnak, M.A.M.C. van den Berg, Mette Sannes, David A. Cooper, R Garner, Giota Touloumi, JH Darbyshire, S Hutchinson, F Garland, Roel A. Coutinho, Maria Prins, David S. Metzger, C.B. Pedersen, Andrew N. Phillips, D Kwart, S Melnick, James J. Goedert, P Cunningham, Anne Eskild, R Brettie, Barry Evans, P Rosenberg, D Osmond, Susan Buchbinder, L Kingsley, Laurence Meyer, M Hilgartner, E Gomperts, R Zangerle, Farewell, G. Rezza, Martin Rickenbach, P Giangrande, I Ruiz, Jeanette Vizzard, Mads Melbye, C Hawkes, Mark Winter, Nicholas E. Day, P Renzullo, C Altisent, Daniela De Angelis, Philippe Vanhems, C Lee, John M. Kaldor, Alessandro Cozzi Lepri, Olga Katsarou, J Wilde, Anastasia Karafoulidou, B Tindall, Faroudy Boufassa, A Babiker, George E. Woody, C Hendrix, AM Johnson, JI Lorenzo, Harold W. Jaffe, Ole Kirk, Johan N. Bruun, L Schrager, Eric Vittinghoff, P Pezzotti, O Berglund, Collaborative Grp Aids Incubation, W Winkelstein, CA Sabin, K Hoots, Patrick Francioli, J Mosley, A Downs, François Dabis, J Del Amo, Beryl A. Koblin, Osamah Hamouda, Noel Gill, S Donfield, E Operskalski, T Sharkey, A Moss, B van Benthem, David J. Goldberg, B Evatt, D Ewart, Kholoud Porter, M Schechter, Beral
Publikováno v:
ResearcherID
Summary Background We used data from Europe, North America, and Australia to assess the effect of exposure category on the AIDS incubation period and HIV-1 survival and whether the effect of age at seroconversion varies with exposure category and wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f66a777b7225fd20fe54e8dd2cf2bde8
https://doi.org/10.1016/s0140-6736(00)02061-4
https://doi.org/10.1016/s0140-6736(00)02061-4
Autor:
Manuel D. Carcao, H. Marijke van den Berg, Rolf Ljung, Maria Elisa Mancuso, C Altisent, G Auerswald, E Chalmers, H Chambost, A Cid, S Claeyssens, N Clausen, K Fischer, Van Creveld Kliniek, Ch van Geet, K Peerlinck, R Kobelt, W Kreuz, C Escuriola, K Kurnik, R Liesner, R Ljung, A Mäkipernaa, A Molinari, W Muntean, J Oldenburg, R Pérez Garrido, P Petrini, H Platokouki, A Rafowicz, E Santagostino, ME Mancuso, A Thomas, M Williams, SC Gouw, HM van den Berg, G Kenet, M Carcao, G Rivard
Publikováno v:
Blood. 121(19)
Phenotypic variability is well recognized in severe hemophilia A. A few studies, mainly in adults treated lifelong on demand, suggest that bleeding phenotype correlates with factor VIII gene (F8) mutation type. Because treatment regimens influence ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::508ff3e269c64dd0a27fb7f14b4ef016
https://pubmed.ncbi.nlm.nih.gov/23660857
https://pubmed.ncbi.nlm.nih.gov/23660857
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 18(5)
Acquired haemophilia A (AH) is defined as the presence of autoantibodies or inhibitors against factor VIII (FVIII) with a clinical bleeding onset that can be life-threatening. Immunosuppressant therapy must be initiated rapidly to eradicate the inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::824b63036da28c293684623a5d2863cf
https://pubmed.ncbi.nlm.nih.gov/22429259
https://pubmed.ncbi.nlm.nih.gov/22429259